precision

CJC-1295-Without-DAC

Price range: $ 80 through $ 140

CJC-1295 Without DAC, commonly known as Modified GRF (1-29), is a synthetic 29-amino-acid research peptide derived from the N-terminal region of human growth hormone-releasing hormone. It contains four amino-acid substitutions and a C-terminal amide that distinguish it from the native GHRH fragment. It is supplied for controlled laboratory studies involving peptide characterization, receptor-binding behavior, molecular signaling, enzymatic stability, and structure-activity relationships. Researchers may evaluate CJC-1295 Without DAC through in vitro receptor assays, chromatographic analysis, mass spectrometry, comparative sequence studies, and stability testing performed under defined experimental conditions.

SKU: N/A Category:

Product Specifications

Form: Lyophilized peptide powder

Strength: Add the product-specific strength

Peptide Length: 29 amino-acid residues

Peptide Classification: Synthetic tetrasubstituted GHRH (1-29) analog research peptide

Modified Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

Structural Modifications: D-Ala substitution at position 2, Gln substitution at position 8, Ala substitution at position 15, Leu substitution at position 27, and C-terminal amidation

Molecular Formula: C152H252N44O42 for the amidated free peptide form

Molecular Weight: Approximately 3368.0 g/mol for the amidated free peptide form

CAS Number: 863288-34-0

Purity: ≥99%, where confirmed through batch-specific HPLC analysis

Appearance: White to off-white lyophilized powder

Intended Use: Laboratory research and analytical applications only

Research Applications

  • Analytical characterization using HPLC, UPLC, and LC-MS workflows
  • In vitro investigation of GHRH receptor-binding behavior
  • Evaluation of receptor-associated intracellular signaling pathways
  • Structure-activity analysis of modified GHRH-related peptide sequences
  • Comparative assessment of native and substituted GRF fragments
  • Peptide identity, purity, molecular weight, and structural integrity analysis
  • Stability profiling under defined temperature, pH, buffer, and storage conditions

Quality Documentation

A batch-specific Certificate of Analysis and applicable analytical documentation should be available for each lot. Peptide identity, modified sequence, amidation status, purity, molecular weight, formulation details, and batch information should be verified against the records supplied with the individual product. Molecular formula and molecular weight may vary when the material is supplied as an acetate salt, hydrated form, or alternative formulation.

For Laboratory Research Use Only

This product is intended exclusively for controlled laboratory and in vitro research. Not for human or veterinary use. Not for diagnostic, therapeutic, clinical, cosmetic, or household applications.

strength

10MG, 5MG

Reviews

There are no reviews yet.

Be the first to review “CJC-1295-Without-DAC”

Your email address will not be published. Required fields are marked *

Scroll to Top